Envy Medical Rolls Out Lumixyl Brightening System

2010-03-09 | 06:27

Professional-grade treatment for hyperpigmentation.

Envy Medical, Inc., New York, has unveiled the Lumixyl Brightening System, which it says is a multi-faceted approach to effectively treat hyperpigmentation without irritation or other side effects associated with prescription Hydroquinone or retinoids.

The Lumixyl Topical Brightening System is an entirely new approach to naturally brighter, more vibrant skin, representing a new physician-grade standard in skincare," explained Dr. Basil Hantash, a board certified Stanford-trained dermatologist and vice-chairman of the board at Envy Medical, who also helped develop the Lumixyl peptide technology. "An innovation in skin brightening technology, the four products in the Lumixyl Brightening System work synergistically to target existing hyperpigmentation and to prevent its recurrence. For most patients these formulations can eliminate the need to use hydroquinone or its bi-products."

The regimen includes Active-Prep Cleanser, Topical Brightening Creme, GlycoPeel 20 Rapid Exfoliating Lotio and Moisture-Lock Sunscreen SPF 30. The products are ideal for all skin types. Lumixyl Brightening System retails for $270 for four full size products.

Developed by Envy Medical, Inc. and dermatological researchers at Stanford University, Lumixyl products are made exclusively for dermatologists, plastic surgeons and skin oriented aesthetic physicians. The products are manufactured and sold by Envy Medical in the United States and distributed internationally by Toronto Canada-based Basis Medical Technologies.